Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 2 Thyroid Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Liver Cirrhosis 1 HER2-positive Breast Cancer 1 Glioma 1 Glioblastoma 1 Cytoreductive Surgery 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms, Male 1

Interventions

Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cytoreductive Surgery × Fluorodeoxyglucose F18 × Clear all

NCT05390021 2024-04-02

PET/MRI in Endometrial Cancer

Massachusetts General Hospital

Phase NA Withdrawn

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡